Role of CX3CR1-expressing Cells in Hematologic Malignancy

Clinical trial NCT02885623 · UNKNOWN

Trial details

NCT number: NCT02885623
Sponsor: Saint Vincent's Hospital, Korea
Status: UNKNOWN
Study type: OBSERVATIONAL

CX3CR1 Protein Diffuse Large B Cell Lymphoma Multiple Myeloma

Start date: 2016-08-01
Primary completion: 2019-08-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.